USNA
Usana Health Sciences Stock Analysis
AI Rating
- Quality7/10
- Growth↓ 0/10
- Momentum↓ 3/10
USNA Growth
- Revenue Y/Y↑ 5.88%
- EPS Y/Y↓ -69.01%
- FCF Y/Y↓ -71.55%
USNA Profitability
- Gross margin ↑ 79.20%
- EPS margin↓ 1.90%
- ROIC↑ 28.70%
USNA Risk
- Debt / Equity↓ 0.0
- Debt / FCF↓ 0.0
- Interest coverage↑ 56.7
Usana Health Sciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.